The interactive tool, which debuted last year, recently underwent an update, according to a post on the CMS blog. With the update, CMS has now added two avenues of information: information on drugs purchased for Medicaid beneficiaries and high-level information on rebates provided by drug manufacturers. This addition updates components from the original dashboard in which users were able to track trends by viewing drugs in Medicare Part B and D.
Information on the dashboard also includes details related to drug spending, number of prescription fills, brand and generic name, uses and the name of the manufacturer.
More articles on health IT:
AHA advocates for regulatory flexibility in EHR incentives
Employers search an average of 96 days to find applicants proficient in cloud security, report finds
Ambra Health unveils RADxx initiative to encourage female leadership in digital health, informatics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.